Pazopanib

Hepatotoxicity

  • Severe and fatal hepatotoxicity has been observed in clinical studies.
  • Monitor hepatic function and interrupt, reduce, or discontinue dosing as recommended. 

Patient counseling

Medical guidelines

Package inserts

Additional information

New drug approval: October 2009

Updated: January 2018